A few days ago, my colleague Cory Renauer wrote that there was a big week aheadfor Eli Lilly and Company (NYSE: LLY). Cory was right. And we now know the outcomes of several of the big news stories for the drugmaker.
Is Eli Lilly and Company a Buy?
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться